User login
Key clinical point: Gastric transcatheter chemoembolization (GTC) is a safe and effective alternative treatment method for advanced gastric cancer with obstruction.
Major finding: All patients achieved successful selection of tumor-feeding blood vessels and injection of chemotherapeutics and embolic agents, while 22 achieved a gastric outlet obstruction scoring system (GOOSS) score of ≥2. The median time of GTC was 83 minutes, and the median time of hospitalization after GTC was 3 days. One patient experienced abdominal pain during and after GTC. The pre- and post-intervention GOOSS scores were 1 and 2, respectively (P = .000).
Study details: This retrospective study included 42 patients with advanced gastric cancer complicated with obstruction who underwent GTC.
Disclosures: This study was supported by the Chongqing Science and Health Joint Project, China. The authors declared no conflicts of interest.
Source: Peng D et al. Gastric transcatheter chemoembolization can resolve advanced gastric cancer presenting with obstruction. Front Surg. 2022;9:1004064 (Oct 20). Doi: 10.3389/fsurg.2022.1004064
Key clinical point: Gastric transcatheter chemoembolization (GTC) is a safe and effective alternative treatment method for advanced gastric cancer with obstruction.
Major finding: All patients achieved successful selection of tumor-feeding blood vessels and injection of chemotherapeutics and embolic agents, while 22 achieved a gastric outlet obstruction scoring system (GOOSS) score of ≥2. The median time of GTC was 83 minutes, and the median time of hospitalization after GTC was 3 days. One patient experienced abdominal pain during and after GTC. The pre- and post-intervention GOOSS scores were 1 and 2, respectively (P = .000).
Study details: This retrospective study included 42 patients with advanced gastric cancer complicated with obstruction who underwent GTC.
Disclosures: This study was supported by the Chongqing Science and Health Joint Project, China. The authors declared no conflicts of interest.
Source: Peng D et al. Gastric transcatheter chemoembolization can resolve advanced gastric cancer presenting with obstruction. Front Surg. 2022;9:1004064 (Oct 20). Doi: 10.3389/fsurg.2022.1004064
Key clinical point: Gastric transcatheter chemoembolization (GTC) is a safe and effective alternative treatment method for advanced gastric cancer with obstruction.
Major finding: All patients achieved successful selection of tumor-feeding blood vessels and injection of chemotherapeutics and embolic agents, while 22 achieved a gastric outlet obstruction scoring system (GOOSS) score of ≥2. The median time of GTC was 83 minutes, and the median time of hospitalization after GTC was 3 days. One patient experienced abdominal pain during and after GTC. The pre- and post-intervention GOOSS scores were 1 and 2, respectively (P = .000).
Study details: This retrospective study included 42 patients with advanced gastric cancer complicated with obstruction who underwent GTC.
Disclosures: This study was supported by the Chongqing Science and Health Joint Project, China. The authors declared no conflicts of interest.
Source: Peng D et al. Gastric transcatheter chemoembolization can resolve advanced gastric cancer presenting with obstruction. Front Surg. 2022;9:1004064 (Oct 20). Doi: 10.3389/fsurg.2022.1004064